The role of Foxp3+regulatory T-cells in endometriosis: a potential controlling mechanism for a complex, chronic immunological condition

被引:121
作者
Berbic, Marina [1 ]
Hey-Cunningham, Alison J. [1 ]
Ng, Cecilia [1 ]
Tokushige, Natsuko [1 ]
Ganewatta, Subha [1 ]
Markham, Robert [1 ]
Russell, Peter [1 ]
Fraser, Ian S. [1 ]
机构
[1] Univ Sydney, Dept Obstet & Gynaecol, Queen Elizabeth Res Inst Mothers & Infants 2, Sydney, NSW 2006, Australia
关键词
regulatory T-cells; Foxp3; endometriosis; endometrium; peritoneal lesions; ENDOTHELIAL GROWTH-FACTOR; SUPPRESSIVE FUNCTION; ECTOPIC ENDOMETRIUM; ANGIOGENIC FACTORS; EXPRESSION; FOXP3; LEUKOCYTES; WOMEN; CD4(+)CD25(+); INFERTILITY;
D O I
10.1093/humrep/deq020
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Endometriosis is an inflammatory condition, associated with highly dysregulated immune response at both uterine and peritoneal levels. Surprisingly, Foxp3+ regulatory T-cells, which control and suppress a range of immune responses, have not previously been investigated in endometriosis. Immunohistochemical analysis of Foxp3+ cells in 127 eutopic endometrial samples and 59 ectopic peritoneal lesions revealed that these immune cell populations are highly disturbed in women suffering from endometriosis. We showed that Foxp3+ cells remained highly up-regulated during the secretory phase of the menstrual cycle, while at this time their expression is significantly down-regulated in women without endometriosis (P < 0.001). Foxp3+ cells were detected in the stroma of 18 of the 59 peritoneal endometriotic lesions, but not in the surrounding or control peritoneal tissue. We propose that in eutopic endometrium in women with endometriosis Foxp3+ cells decrease the ability of newly recruited immune cell populations to effectively recognize and target endometrial antigens shed during menstruation, allowing their survival and ability to implant in ectopic sites. At these ectopic sites, variable expression of Foxp3+ cells within some peritoneal endometriotic lesions is likely to be linked to the characteristics and stage of individual lesion development and be playing key roles in pathogenesis and progression of this unique condition.
引用
收藏
页码:900 / 907
页数:8
相关论文
共 42 条
[1]   Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status, and pelvic pain [J].
Akoum, Ali ;
Metz, Christine N. ;
Al-Akoum, Mahera ;
Kats, Rouslan .
FERTILITY AND STERILITY, 2006, 85 (05) :1379-1385
[2]  
ALJEFOUT M, 2009, OBSTET GYNECOL, V4, P61
[3]   Expansion of CD4+CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle:: Implications for human reproduction [J].
Arruvito, Lourdes ;
Sanz, Marianela ;
Banham, Alison H. ;
Fainboim, Leonardo .
JOURNAL OF IMMUNOLOGY, 2007, 178 (04) :2572-2578
[4]   Macrophage expression in endometrium of women with and without endometriosis [J].
Berbic, Marina ;
Schulke, Lauren ;
Markham, Robert ;
Tokushige, Natsuko ;
Russell, Peter ;
Fraser, Ian S. .
HUMAN REPRODUCTION, 2009, 24 (02) :325-332
[5]  
BONDZA PK, 2006, WORLD ENDO SOC E J, V8, P7
[6]   Endometriosis is sustained by tumour necrosis factor-α [J].
Bullimore, DW .
MEDICAL HYPOTHESES, 2003, 60 (01) :84-88
[7]   Intraepithelial leukocytes in endometriosis and adenomyosis: comparison of eutopic and ectopic endometrium with normal endometrium [J].
Bulmer, JN ;
Jones, RK ;
Searle, RF .
HUMAN REPRODUCTION, 1998, 13 (10) :2910-2915
[8]   Role of aromatase in endometrial disease [J].
Bulun, SE ;
Yang, SJ ;
Fang, ZJ ;
Gurates, B ;
Tamura, M ;
Zhou, JF ;
Sebastian, S .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 79 (1-5) :19-25
[9]   Nonhuman Primate Models for Translational Research in Endometriosis [J].
D'Hooghe, T. M. ;
Kyama, C. M. ;
Chai, D. ;
Fassbender, A. ;
Vodolazkaia, A. ;
Bokor, A. ;
Mwenda, J. M. .
REPRODUCTIVE SCIENCES, 2009, 16 (02) :152-161
[10]   Vascular endothelial growth factor (VEGF) in endometriosis [J].
Donnez, J ;
Smoes, P ;
Gillerot, S ;
Casanas-Roux, F ;
Nisolle, M .
HUMAN REPRODUCTION, 1998, 13 (06) :1686-1690